Laponite-Based Nanocomposite Hydrogels for Drug Delivery Applications

Hydrogels are widely used for therapeutic delivery applications due to their biocompatibility, biodegradability, and ability to control release kinetics by tuning swelling and mechanical properties. However, their clinical utility is hampered by unfavorable pharmacokinetic properties, including high...

Full description

Bibliographic Details
Main Authors: Samuel T. Stealey, Akhilesh K. Gaharwar, Silviya Petrova Zustiak
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/16/6/821
_version_ 1797593145212403712
author Samuel T. Stealey
Akhilesh K. Gaharwar
Silviya Petrova Zustiak
author_facet Samuel T. Stealey
Akhilesh K. Gaharwar
Silviya Petrova Zustiak
author_sort Samuel T. Stealey
collection DOAJ
description Hydrogels are widely used for therapeutic delivery applications due to their biocompatibility, biodegradability, and ability to control release kinetics by tuning swelling and mechanical properties. However, their clinical utility is hampered by unfavorable pharmacokinetic properties, including high initial burst release and difficulty in achieving prolonged release, especially for small molecules (<500 Da). The incorporation of nanomaterials within hydrogels has emerged as viable option as a method to trap therapeutics within the hydrogel and sustain release kinetics. Specifically, two-dimensional nanosilicate particles offer a plethora of beneficial characteristics, including dually charged surfaces, degradability, and enhanced mechanical properties within hydrogels. The nanosilicate–hydrogel composite system offers benefits not obtainable by just one component, highlighting the need for detail characterization of these nanocomposite hydrogels. This review focuses on Laponite, a disc-shaped nanosilicate with diameter of 30 nm and thickness of 1 nm. The benefits of using Laponite within hydrogels are explored, as well as examples of Laponite–hydrogel composites currently being investigated for their ability to prolong the release of small molecules and macromolecules such as proteins. Future work will further characterize the interplay between nanosilicates, hydrogel polymer, and encapsulated therapeutics, and how each of these components affect release kinetics and mechanical properties.
first_indexed 2024-03-11T02:03:42Z
format Article
id doaj.art-e0bc3aba49a6443e84d470bce5a8067c
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-11T02:03:42Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-e0bc3aba49a6443e84d470bce5a8067c2023-11-18T12:01:59ZengMDPI AGPharmaceuticals1424-82472023-05-0116682110.3390/ph16060821Laponite-Based Nanocomposite Hydrogels for Drug Delivery ApplicationsSamuel T. Stealey0Akhilesh K. Gaharwar1Silviya Petrova Zustiak2Department of Biomedical Engineering, Saint Louis University, Saint Louis, MO 63103, USADepartment of Biomedical Engineering, Texas A&M University, College Station, TX 77433, USADepartment of Biomedical Engineering, Saint Louis University, Saint Louis, MO 63103, USAHydrogels are widely used for therapeutic delivery applications due to their biocompatibility, biodegradability, and ability to control release kinetics by tuning swelling and mechanical properties. However, their clinical utility is hampered by unfavorable pharmacokinetic properties, including high initial burst release and difficulty in achieving prolonged release, especially for small molecules (<500 Da). The incorporation of nanomaterials within hydrogels has emerged as viable option as a method to trap therapeutics within the hydrogel and sustain release kinetics. Specifically, two-dimensional nanosilicate particles offer a plethora of beneficial characteristics, including dually charged surfaces, degradability, and enhanced mechanical properties within hydrogels. The nanosilicate–hydrogel composite system offers benefits not obtainable by just one component, highlighting the need for detail characterization of these nanocomposite hydrogels. This review focuses on Laponite, a disc-shaped nanosilicate with diameter of 30 nm and thickness of 1 nm. The benefits of using Laponite within hydrogels are explored, as well as examples of Laponite–hydrogel composites currently being investigated for their ability to prolong the release of small molecules and macromolecules such as proteins. Future work will further characterize the interplay between nanosilicates, hydrogel polymer, and encapsulated therapeutics, and how each of these components affect release kinetics and mechanical properties.https://www.mdpi.com/1424-8247/16/6/821nanosilicatenanoclaynanocompositehydrogelLaponitedrug delivery
spellingShingle Samuel T. Stealey
Akhilesh K. Gaharwar
Silviya Petrova Zustiak
Laponite-Based Nanocomposite Hydrogels for Drug Delivery Applications
Pharmaceuticals
nanosilicate
nanoclay
nanocomposite
hydrogel
Laponite
drug delivery
title Laponite-Based Nanocomposite Hydrogels for Drug Delivery Applications
title_full Laponite-Based Nanocomposite Hydrogels for Drug Delivery Applications
title_fullStr Laponite-Based Nanocomposite Hydrogels for Drug Delivery Applications
title_full_unstemmed Laponite-Based Nanocomposite Hydrogels for Drug Delivery Applications
title_short Laponite-Based Nanocomposite Hydrogels for Drug Delivery Applications
title_sort laponite based nanocomposite hydrogels for drug delivery applications
topic nanosilicate
nanoclay
nanocomposite
hydrogel
Laponite
drug delivery
url https://www.mdpi.com/1424-8247/16/6/821
work_keys_str_mv AT samueltstealey laponitebasednanocompositehydrogelsfordrugdeliveryapplications
AT akhileshkgaharwar laponitebasednanocompositehydrogelsfordrugdeliveryapplications
AT silviyapetrovazustiak laponitebasednanocompositehydrogelsfordrugdeliveryapplications